Approval · Notice of Compliance 9018 · 2007
NITRO-DUR 0.2: Notice of Compliance 9018
Issued September 11, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9018
- Date
- September 11, 2007
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antianginal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NITRO-DUR 0.2 | 01911910 | Marketed |
| NITRO-DUR 0.4 | 01911902 | Marketed |
| NITRO-DUR 0.6 | 01911929 | Marketed |
| NITRO-DUR 0.8 | 02011271 | Marketed |
Medicinal ingredients
- NITROGLYCERIN 40 MG per 10SQCM
- NITROGLYCERIN 80 MG per 20SQCM
- NITROGLYCERIN 120 MG per 30SQCM
- NITROGLYCERIN 160 MG per 40SQCM